-
Signature
-
Kaushik Ghoshal, President SaaS Business
-
Issuer symbol
-
RMD
-
Transactions as of
-
12 Aug 2024
-
Net transactions value
-
-$1,201,944
-
Form type
-
4
-
Filing time
-
13 Aug 2024, 15:51:40 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$199,839 |
+2,086 |
+16% |
$95.80 |
15,118 |
12 Aug 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$658,817 |
+6,877 |
+45% |
$95.80 |
21,995 |
12 Aug 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$105,401 |
+1,037 |
+4.7% |
$101.64 |
23,032 |
12 Aug 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$2,166,000 |
-10,000 |
-43% |
$216.60 |
13,032 |
12 Aug 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-2,086 |
-100% |
$0.000000* |
0 |
12 Aug 2024 |
ResMed Common Stock |
2,086 |
$95.80 |
Direct |
F1, F2 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-6,877 |
-100% |
$0.000000* |
0 |
12 Aug 2024 |
ResMed Common Stock |
6,877 |
$95.80 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-1,037 |
-10% |
$0.000000 |
9,260 |
12 Aug 2024 |
ResMed Common Stock |
1,037 |
$101.64 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: